Why the study?
Does adverse LV remodeling at 6 months (defined as ≥12% increase in both LVESV and LVEDV by CMR) predict worse long-term clinical outcomes in stable reperfused STEMI patients?
Population
Stable reperfused patients with ST-segment-elevation myocardial infarction
Comparison
Adverse LV remodeling vs adverse LV remodeling with compensation, reverse LV remodeling, and no LV remodeling
Design
Cohort study
Follow-up
6 months
Authors
Loading...
Adverse LV remodeling by this CMR definition flags higher-risk post-STEMI patients; hypothesis-generating and requires prospective validation before guiding care.
Does adverse LV remodeling at 6 months (defined as ≥12% increase in both LVESV and LVEDV by CMR) predict worse long-term clinical outcomes in stable reperfused STEMI patients?
Adverse LV remodeling defined by a ≥12% increase in both LVESV and LVEDV at 6 months post-STEMI identifies patients at higher risk for worse long-term clinical outcomes.
Bulluck et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: